Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura Pellei

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|April 15, 2020
Synthesis and Cytotoxic Activity Evaluation of New Cu(I) Complexes of Bis(pyrazol-1-yl) Acetate Ligands Functionalized with an NMDA Receptor AntagonistMaura Pellei, Luca Bagnarelli, Lorenzo Luciani, et al.
International Journal of Molecular Sciences|August 26, 2022
Exploring the Antitumor Potential of Copper Complexes Based on Ester Derivatives of Bis(pyrazol-1-yl)acetate LigandsMaura Pellei, Carlo Santini, Luca Bagnarelli, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|March 22, 2024
Cu(I) Coordination Compounds Conjugated to Au Nanorods for Future Applications in Drug Delivery: Insights in Molecular, Electronic and Cu Local Structure in Solid and Liquid PhaseAlberto Lopez, Simone Amatori, Elena Olivieri, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 4, 2026
Structural and Biological Insights Into Copper(I) Phosphane Complexes With Boron-Phenylated Poly(3-(CF<sub>3</sub>)Pyrazolyl)- and Poly(6-(CF<sub>3</sub>)-2-pyridyl)-BoratesVo Quang Huy Phan, Jo' Del Gobbo, Mukundam Vanga, et al.
Dalton Transactions (Cambridge, England : 2003)|October 23, 2020
Development of new and efficient copper(II) complexes of hexyl bis(pyrazolyl)acetate ligands as catalysts for allylic oxidationSerena Gabrielli, Maura Pellei, Iole Venditti, et al.
ACS Omega|May 25, 2026
Synthesis, Structural Insights, and In Vitro Evaluation of Novel Silver Complexes Supported by Amantadine-Functionalized Bis(pyrazolyl)acetate Ligands as Anticancer AgentsMaura Pellei, Michele De Franco, Carlo Santini, et al.
Journal of Medicinal Chemistry|October 3, 2015
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane RingAlessandro Bonifazi, Fabio Del Bello, Valerio Mammoli, et al.
Inorganic Chemistry|March 14, 2022
Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor EffectsFabio Del Bello, Maura Pellei, Luca Bagnarelli, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer CellsMaria Beatrice Morelli, Consuelo Amantini, Massimo Nabissi, et al.
International Journal of Molecular Sciences|February 13, 2026
Synthesis, Structural Studies, and Biological Evaluation of Copper(I) and Copper(II) Complexes Supported by Bis(pyrazol-1-yl)acetate Ligand Functionalized with Amantadine for the Treatment of GlioblastomaSofia Migani, Giuseppina Bozzuto, Annarica Calcabrini, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|April 15, 2020
Synthesis and Cytotoxic Activity Evaluation of New Cu(I) Complexes of Bis(pyrazol-1-yl) Acetate Ligands Functionalized with an NMDA Receptor AntagonistMaura Pellei, Luca Bagnarelli, Lorenzo Luciani, et al.
International Journal of Molecular Sciences|August 26, 2022
Exploring the Antitumor Potential of Copper Complexes Based on Ester Derivatives of Bis(pyrazol-1-yl)acetate LigandsMaura Pellei, Carlo Santini, Luca Bagnarelli, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|March 22, 2024
Cu(I) Coordination Compounds Conjugated to Au Nanorods for Future Applications in Drug Delivery: Insights in Molecular, Electronic and Cu Local Structure in Solid and Liquid PhaseAlberto Lopez, Simone Amatori, Elena Olivieri, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 4, 2026
Structural and Biological Insights Into Copper(I) Phosphane Complexes With Boron-Phenylated Poly(3-(CF<sub>3</sub>)Pyrazolyl)- and Poly(6-(CF<sub>3</sub>)-2-pyridyl)-BoratesVo Quang Huy Phan, Jo' Del Gobbo, Mukundam Vanga, et al.
Dalton Transactions (Cambridge, England : 2003)|October 23, 2020
Development of new and efficient copper(II) complexes of hexyl bis(pyrazolyl)acetate ligands as catalysts for allylic oxidationSerena Gabrielli, Maura Pellei, Iole Venditti, et al.
ACS Omega|May 25, 2026
Synthesis, Structural Insights, and In Vitro Evaluation of Novel Silver Complexes Supported by Amantadine-Functionalized Bis(pyrazolyl)acetate Ligands as Anticancer AgentsMaura Pellei, Michele De Franco, Carlo Santini, et al.
Journal of Medicinal Chemistry|October 3, 2015
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane RingAlessandro Bonifazi, Fabio Del Bello, Valerio Mammoli, et al.
Inorganic Chemistry|March 14, 2022
Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor EffectsFabio Del Bello, Maura Pellei, Luca Bagnarelli, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer CellsMaria Beatrice Morelli, Consuelo Amantini, Massimo Nabissi, et al.
International Journal of Molecular Sciences|February 13, 2026
Synthesis, Structural Studies, and Biological Evaluation of Copper(I) and Copper(II) Complexes Supported by Bis(pyrazol-1-yl)acetate Ligand Functionalized with Amantadine for the Treatment of GlioblastomaSofia Migani, Giuseppina Bozzuto, Annarica Calcabrini, et al.
Pageof 7